Resistant hypertension is defined as uncontrolled blood pressure (BP ≥ 140/90mmHg) despite the current use of three or more antihypertensive drugs at full doses, including a diuretic. Obstructive Sleep Apnea (OSA) is at high risk for cardiovascular morbidity and is highly prevalent in patients with resistant hypertension. The prospective observational POP-ART study will assess the efficacy of continuous positive airway pressure (CPAP) treatment on BP in patients with resistant hypertension and collect data from usual care.
Obstructive Sleep Apnea is highly prevalent in patients with resistant hypertension and several studies have assessed the effect of CPAP treatment on BP. But only few studies have raised data about the effect of CPAP treatment on BP in patients with resistant hypertension. Hypertension is moreover associated with increased arterial stiffness, but no data are available in patients with resistant hypertension. The purpose of this study is to demonstrate that OSA has a major impact in resistant hypertension, whose effects on BP and arterial stiffness can partially be reversible with CPAP treatment.
Study Type
OBSERVATIONAL
Enrollment
166
Clinique du Tondu
Bordeaux, France
RECRUITINGBordeaux University Hospital
Bordeaux, France
RECRUITINGClinique des Eaux Claires, Groupe Hospitalier Mutualiste
Grenoble, France
RECRUITINGGrenoble University Hospital
Grenoble, France
RECRUITINGMean variation in BP at 6 months, assessed by 24h ambulatory BP monitoring
Time frame: 6 months from baseline assessment
OSA prevalence in patients with resistant hypertension
Time frame: 6 months
BP variability assessed by home self BP measurments
Time frame: 6 months
Arterial stiffness assessed by pulse wave velocity and QKD interval
Time frame: 6 months
Antihypertensive treatment consumption
Time frame: 6 months
CPAP treatment observance
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.